» Articles » PMID: 36493905

Nanosensitizer-mediated Unique Dynamic Therapy Tactics for Effective Inhibition of Deep Tumors

Overview
Specialty Pharmacology
Date 2022 Dec 9
PMID 36493905
Authors
Affiliations
Soon will be listed here.
Abstract

X-ray and ultrasound waves are widely employed for diagnostic and therapeutic purposes in clinic. Recently, they have been demonstrated to be ideal excitation sources that activate sensitizers for the dynamic therapy of deep-seated tumors due to their excellent tissue penetration. Here, we focused on the recent progress in five years in the unique dynamic therapy strategies for the effective inhibition of deep tumors that activated by X-ray and ultrasound waves. The concepts, mechanisms, and typical nanosensitizers used as energy transducers are described as well as their applications in oncology. The future developments and potential challenges are also discussed. These unique therapeutic methods are expected to be developed as depth-independent, minimally invasive, and multifunctional strategies for the clinic treatment of various deep malignancies.

Citing Articles

Novel Flavin Mononucleotide-Functionalized Cerium Fluoride Nanoparticles for Selective Enhanced X-Ray-Induced Photodynamic Therapy.

Kornienko A, Teplonogova M, Shevelyova M, Popkov M, Popov A, Ivanov V J Funct Biomater. 2024; 15(12).

PMID: 39728173 PMC: 11676406. DOI: 10.3390/jfb15120373.


Ca- and cGAMP-Contained Semiconducting Polymer Nanomessengers for Radiodynamic-Activated Calcium Overload and Immunotherapy.

Cheng D, Luo L, Zhang Q, Song Z, Zhan Y, Tu W Adv Sci (Weinh). 2024; 12(6):e2411739.

PMID: 39679909 PMC: 11809400. DOI: 10.1002/advs.202411739.


Tumour-microenvironment-responsive NaSO nanocrystals encapsulated in hollow organosilica-metal-phenolic networks for cycling persistent tumour-dynamic therapy.

Li Y, Lin J, He Y, Wang K, Huang C, Zhang R Exploration (Beijing). 2024; 4(2):20230054.

PMID: 38855614 PMC: 11022624. DOI: 10.1002/EXP.20230054.


Engineering metabolism to modulate immunity.

Kapnick S, Martin C, Jewell C Adv Drug Deliv Rev. 2023; 204:115122.

PMID: 37935318 PMC: 10843796. DOI: 10.1016/j.addr.2023.115122.


Ferroptosis as a promising therapeutic strategy for melanoma.

Ta N, Jiang X, Zhang Y, Wang H Front Pharmacol. 2023; 14:1252567.

PMID: 37795022 PMC: 10546212. DOI: 10.3389/fphar.2023.1252567.